Details

IRB Study Number 25-679

Status Recruiting

Location Cleveland Clinic Main Campus

Institute Endocrinology and Metabolism Institute

Description

Description

The purpose of this study is to learn more about blood sugar control in polycystic ovarian syndrome.

Inclusion Criteria

Inclusion Criteria

  1. Adult 18-45 years old

  2. Diagnosis of PCOS by usual clinical method such as by Rotterdam criteria

  3. BMI ++>++25 kg/m2

Exclusion Criteria

Exclusion Criteria

  1. Currently on medications that can improve glucose levels such as metformin and glucagon-like receptor 1 agonists (GLP1RA)

  2. Previously intake of above-mentioned medications but less than 3 months since last intake of metformin or less than 6 months since last intake of GLP1RA

  3. Currently on insulin

  4. Does not have Stelo-compatible phone

  5. Fasting glucose ++>++100 mg/dL (because that is the cutoff for prediabetes) (either labs taken within a week after first visit or within 3 months before start of study

  6. HbA1c ++>++ 5.7% (because this is the cutoff for prediabetes) (either labs taken after screening visit or within 3 months before start of study)

  7. History of anorexia or bulimia

  8. Current or previous CGM use

  9. Use of oral contraceptives at time of enrolment

  10. Pregnant or with intent to become pregnant within 6 months (will need to terminate study if gets pregnant as glucose readings will be affected)

  11. Menopausal women

  12. Pacemaker or implantable device

  13. Intake of hydroxyurea, or acetaminophen >4 g a day

  14. Allergy to Stelo components including adhesive